Schistosomiasis (bilharziasis), an endemic parasitic tropical disease found especially in sub-Saharan Africa, causes substantial morbidity and mortality. In developed countries, the disease is typically seen in nonimmune travelers returning from endemic areas.
Tests generally appear in the order most useful for common clinical situations
| Test name: CBC with Platelet Count & Automated Differential |
| ARUP #: 0040003 |
| Methodology: Automated Cell Count with Flow Cell Differential |
| Use: Non-specific testing Blood eosinophilia may be supportive evidence |
| Test name: Ova & Parasite Exam, Fecal (Immunocompromised or Travel History) |
| ARUP #: 2002272 |
| Methodology: Qualitative Concentration Technique/Trichrome Stain/Microscopic Evaluation |
| Use: Diagnose schistosomiasis caused by S. mansoni or S. japonicum Pertinent travel history, exposure history or high pre-test probability for parasitic infection greater than or equal to 30-50-day interval from skin penetration to egg laying |
| Limitations: Stool antigen testing is the optimal test method for determining the parasitic presence of Giardia duodenalis(synonyms Giardia lamblia, Giardia intestinalis), Cryptosporidium spp, or Entamoeba histolytica Ova and parasite exam does not specifically detect Cryptosporidium, Cyclospora, Isospora, and Microsporidia For Cryptosporidium, refer to the Cryptosporidium Antigen by EIA test; for Cyclospora and Isospora, refer to Parasitology Stain by Modified Acid-Fast; for Microsporidia, refer to Microsporidia Stain Ova generally not detected early in the disease |
| Follow-up: If organism is detected in formalin-fixed sample, follow up with subsequent viability testing in unpreserved specimen to differentiate between acute, chronic and treated infection in patients with an immunocompromised condition |
| Test name: Ova and Parasite Exam, Body Fluid or Urine |
| ARUP #: 2002277 |
| Methodology: Qualitative Concentration Technique/Microscopic Evaluation |
| Use: Diagnose schistosomiasis caused by S. haematobium Use urine specimen |
| Test name: Schistosoma Antibody, IgG |
| ARUP #: 0099411 |
| Methodology: Semi-Quantitative Enzyme-Linked Immunosorbent Assay |
| Use: May aid in the diagnosis of schistosomiasis in patients from non-endemic areas when stool and urine tests are negative Generally negative at onset of clinical signs Seroconversion occurs on average 30 days after symptoms and ~6 weeks after contact with contaminated water |
| Limitations: Overall sensitivity 97%; specificity 92% Sensitivity for S. japonicum <50% Sensitivity for S. haematobium 95% False-positive results due to cross-reactivity may occur in samples positive for malaria, filariasis, Toxocara, Leishmania, Epstein-Barr virus Single test cannot distinguish active from past infection |